BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38885876)

  • 1. FcRn inhibition reduces bullous pemphigoid anti-basement membrane zone IgG deposition and blistering in 3D human skin equivalents.
    Bao L; Perez White BE; Chang RC; Li J; Vanderheyden K; Verheesen P; Sips M; Brinkhaus M; Amber KT
    J Invest Dermatol; 2024 Jun; ():. PubMed ID: 38885876
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-glomerular basement membrane nephritis and bullous pemphigoid caused by distinct anti-alpha 3(IV)NC1 and anti-BP180 antibodies in a patient with Crohn's disease.
    Plaisier E; Borradori L; Hellmark T; Wattiaux MJ; Flageul B; Mougenot B; Ronco P
    Am J Kidney Dis; 2002 Sep; 40(3):649-54. PubMed ID: 12200819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
    Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J
    Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
    Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.
    Pigors M; Patzelt S; Reichhelm N; Dworschak J; Khil'chenko S; Emtenani S; Bieber K; Hofrichter M; Kamaguchi M; Goletz S; Köhl G; Köhl J; Komorowski L; Probst C; Vanderheyden K; Balbino B; Ludwig RJ; Verheesen P; Schmidt E
    J Pathol; 2024 Feb; 262(2):161-174. PubMed ID: 37929639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
    Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
    Front Immunol; 2022; 13():874108. PubMed ID: 35514989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous Pemphigoid With a Dual Pattern of Glomerular Immune Complex Disease.
    Hoorn EJ; Taams NE; Hurskainen T; Salih M; Weening JJ; Jonkman MF; Pas HH; Schreurs MW
    Am J Kidney Dis; 2016 Feb; 67(2):302-6. PubMed ID: 26616334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm.
    Imanishi A; Imanishi H; Hiroyasu S; Ozawa T; Koga H; Ishii N; Kitajima Y; Hashimoto T; Tsuruta D
    Med Mol Morphol; 2016 Jun; 49(2):89-97. PubMed ID: 26658728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
    Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning of a cDNA encoding the porcine type XVII collagen noncollagenous 16 A domain and localization of the domain to the upper part of porcine skin basement membrane zone.
    Xu L; Olivry T; Chan LS
    Vet Dermatol; 2004 Jun; 15(3):146-51. PubMed ID: 15214950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoid.
    Iwata H; Kamaguchi M; Ujiie H; Ujiie I; Natsuga K; Nishie W; Shimizu H
    J Pathol; 2019 Mar; 247(3):371-380. PubMed ID: 30426510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2).
    Olivry T; Chan LS; Xu L; Chace P; Dunston SM; Fahey M; Marinkovich MP
    Vet Pathol; 1999 Jul; 36(4):328-35. PubMed ID: 10421100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone.
    Peters MS; Rogers RS
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):761-70. PubMed ID: 2654216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.
    Oswald E; Sesarman A; Franzke CW; Wölfle U; Bruckner-Tuderman L; Jakob T; Martin SF; Sitaru C
    PLoS One; 2012; 7(2):e31066. PubMed ID: 22328927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens.
    Trüeb RM; Didierjean L; Fellas A; Elias A; Borradori L
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):338-44. PubMed ID: 10025864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders.
    Opelka B; Schmidt E; Goletz S
    Front Immunol; 2022; 13():948108. PubMed ID: 36032160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
    Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
    Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
    Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
    J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.